Statin Treatment Does Not Cause Cancer**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 52, Issue 14, 2008, Pages 1148-1149

  Steinberg, Daniel ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

cancer; low density lipoprotein; statins

Indexed keywords

HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

CANCER RISK; CHOLESTEROL BLOOD LEVEL; DRUG SAFETY; EDITORIAL; HIGH RISK PATIENT; HUMAN; NEOPLASM; PRIORITY JOURNAL; PROTEIN EXPRESSION; RISK ASSESSMENT;

CHOLESTEROL, LDL; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; META-ANALYSIS AS TOPIC; NEOPLASMS;

EID: 51649112146     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2008.06.036     Document Type: Editorial

References (15)

1. Alsheikh-Ali A.A., Maddukuri P.V., Han H., and Karas R.H. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials. J Am Coll Cardiol 50 (2007) 409-418
2. LaRosa J.C. Means and ends of statins and low-density lipoprotein cholesterol lowering. J Am Coll Cardiol 50 (2007) 419-420
3. DeMaria A.N., and Ben Yehuda O. Low-density lipoprotein reduction and cancer: not definitive but provocative. J Am Coll Cardiol 50 (2007) 421-422
4. Kjekshus J. Risk associated with statin treatment. (letter). J Am Coll Cardiol 51 (2008) 91
5. Alsheikh-Ali A.A., Trikalinos T.A., Kent D.M., and Karas R.H. Statins, low-density lipoprotein cholesterol, and risk of cancer. J Am Coll Cardiol 52 (2008) 1141-1147
6. Law M.R., Thompson S.G., and Wald N.J. Assessing possible hazards of reducing serum cholesterol. BMJ 308 (1994) 373-379
7. Baigent C., Keech A., Kearney P.M., et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366 (2005) 1267-1278
8. Rose G., and Shipley M.J. Plasma lipids and mortality: a source of error. Lancet 1 (1980) 523-526
9. Tornberg S.A., Holm L.E., Carstensen J.M., and Eklund G.A. Cancer incidence and cancer mortality in relation to serum cholesterol. J Natl Cancer Inst 81 (1989) 1917-1921
10. Vitols S., Gahrton G., Bjorkholm M., and Peterson C. Hypocholesterolaemia in malignancy due to elevated low-density-lipoprotein-receptor activity in tumour cells: evidence from studies in patients with leukaemia. Lancet 2 (1985) 1150-1154
11. Jacobs D., Blackburn H., Higgins M., et al. Report of the Conference on Low Blood Cholesterol: Mortality Associations. Circulation 86 (1992) 1046-1060
12. Mills G.L., and Taylaur C.E. The distribution and composition of serum lipoproteins in eighteen animals. Comp Biochem Physiol B 40 (1971) 489-501
13. Steinberg D., Grundy S.M., Mok H.Y., et al. Metabolic studies in an unusual case of asymptomatic familial hypobetalipoproteinemia with hypolphalipoproteinemia and fasting chylomicronemia. J Clin Invest 64 (1979) 292-301
14. Brown M.S., and Goldstein J.L. A receptor-mediated pathway for cholesterol homeostasis. Science 232 (1986) 34-47
15. Steinberg D., Glass C.K., and Witztum J.L. The evidence mandating earlier and more aggressive treatment of hypercholesterolemia. Circulation 118 (2008) 672-677